OTC Markets OTCQB - Delayed Quote USD

Aurora Spine Corporation (ASAPF)

Compare
0.2874 -0.0356 (-11.02%)
As of 11:54 AM EDT. Market Open.
Loading Chart for ASAPF
DELL
  • Previous Close 0.3230
  • Open 0.3100
  • Bid 0.2900 x --
  • Ask 0.3399 x --
  • Day's Range 0.3100 - 0.3100
  • 52 Week Range 0.1616 - 0.3430
  • Volume 2,500
  • Avg. Volume 17,930
  • Market Cap (intraday) 22.251M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Oct 24, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L spinal fusion system. The company was founded in 2013 and is headquartered in Toronto, Canada.

www.aurora-spine.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ASAPF

View More

Performance Overview: ASAPF

Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ASAPF
0.90%
S&P/TSX Composite index
17.32%

1-Year Return

ASAPF
6.44%
S&P/TSX Composite index
31.23%

3-Year Return

ASAPF
10.04%
S&P/TSX Composite index
17.34%

5-Year Return

ASAPF
1.42%
S&P/TSX Composite index
49.89%

Compare To: ASAPF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASAPF

View More

Valuation Measures

Annual
As of 10/25/2024
  • Market Cap

    26.02M

  • Enterprise Value

    29.24M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.58

  • Price/Book (mrq)

    5.34

  • Enterprise Value/Revenue

    1.82

  • Enterprise Value/EBITDA

    90.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.76%

  • Return on Assets (ttm)

    -2.50%

  • Return on Equity (ttm)

    -14.52%

  • Revenue (ttm)

    16.9M

  • Net Income Avi to Common (ttm)

    -635.51k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    882.05k

  • Total Debt/Equity (mrq)

    73.68%

  • Levered Free Cash Flow (ttm)

    -449.18k

Research Analysis: ASAPF

View More

Revenue vs. Earnings

Revenue 4.77M
Earnings 71.12k
 

Analyst Price Targets

 

Company Insights: ASAPF

People Also Watch